|
|
Gene Symbol |
BRCA1 |
|
Aliases |
BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4, PPP1R53, PSCP, RNF53 |
|
Entrez Gene ID |
|
|
Gene Name |
BRCA1 DNA repair associated |
|
Chromosomal Location |
17q21.31 |
|
HGNC ID |
|
|
Summary |
This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2009]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
Gene |
|
|
Transcript |
ENST00000352993, ENST00000357654, ENST00000471181, ENST00000468300, ENST00000644379, ENST00000586385, ENST00000591534, ENST00000591849, ENST00000493795, ENST00000461221, ENST00000491747, ENST00000484087, ENST00000478531, ENST00000493919, ENST00000487825, ENST00000461574, ENST00000354071, ENST00000634433, ENST00000412061, ENST00000470026, ENST00000652672, ENST00000477152, ENST00000492859, ENST00000497488, ENST00000494123, ENST00000473961, ENST00000642945, ENST00000476777, ENST00000461798, ENST00000489037, ENST00000644555, ENST00000618469 |
|
Protein |
ENSP00000312236, ENSP00000350283, ENSP00000418960, ENSP00000417148, ENSP00000496570, ENSP00000465818, ENSP00000467329, ENSP00000465347, ENSP00000418775, ENSP00000418548, ENSP00000420705, ENSP00000419481, ENSP00000420412, ENSP00000418819, ENSP00000418212, ENSP00000417241, ENSP00000326002, ENSP00000489431, ENSP00000397145, ENSP00000419274, ENSP00000498906, ENSP00000419988, ENSP00000420253, ENSP00000418986, ENSP00000419103, ENSP00000420201, ENSP00000495897, ENSP00000417554, ENSP00000417988, ENSP00000420781, ENSP00000494614, ENSP00000478114
|
|
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000724 |
Biological process |
Double-strand break repair via homologous recombination |
IBA |
21873635 |
GO:0000724 |
Biological process |
Double-strand break repair via homologous recombination |
IDA |
17349954 |
GO:0006301 |
Biological process |
Postreplication repair |
IDA |
17349954 |
GO:0006302 |
Biological process |
Double-strand break repair |
IDA |
22186889 |
GO:0006302 |
Biological process |
Double-strand break repair |
IMP |
17525340, 17643121, 19261748 |
GO:0006357 |
Biological process |
Regulation of transcription by RNA polymerase II |
IMP |
9662397 |
GO:0006359 |
Biological process |
Regulation of transcription by RNA polymerase III |
TAS |
10918303 |
GO:0006915 |
Biological process |
Apoptotic process |
TAS |
10918303 |
GO:0006974 |
Biological process |
Cellular response to DNA damage stimulus |
TAS |
10910365 |
GO:0006978 |
Biological process |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
TAS |
10918303 |
GO:0007059 |
Biological process |
Chromosome segregation |
IMP |
15965487 |
GO:0008630 |
Biological process |
Intrinsic apoptotic signaling pathway in response to DNA damage |
IDA |
14654789 |
GO:0009048 |
Biological process |
Dosage compensation by inactivation of X chromosome |
IBA |
21873635 |
GO:0010212 |
Biological process |
Response to ionizing radiation |
IMP |
17525340, 17643121, 19261748 |
GO:0010575 |
Biological process |
Positive regulation of vascular endothelial growth factor production |
IMP |
23415688 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IMP |
23415688 |
GO:0016567 |
Biological process |
Protein ubiquitination |
IDA |
17349954 |
GO:0030521 |
Biological process |
Androgen receptor signaling pathway |
NAS |
15572661 |
GO:0031398 |
Biological process |
Positive regulation of protein ubiquitination |
IDA |
15965487 |
GO:0033147 |
Biological process |
Negative regulation of intracellular estrogen receptor signaling pathway |
IMP |
17505062 |
GO:0035066 |
Biological process |
Positive regulation of histone acetylation |
IBA |
21873635 |
GO:0035066 |
Biological process |
Positive regulation of histone acetylation |
IDA |
20820192 |
GO:0035067 |
Biological process |
Negative regulation of histone acetylation |
IBA |
21873635 |
GO:0042127 |
Biological process |
Regulation of cell proliferation |
TAS |
10918303 |
GO:0042981 |
Biological process |
Regulation of apoptotic process |
TAS |
10918303 |
GO:0043009 |
Biological process |
Chordate embryonic development |
IBA |
21873635 |
GO:0043627 |
Biological process |
Response to estrogen |
IDA |
8895509 |
GO:0045717 |
Biological process |
Negative regulation of fatty acid biosynthetic process |
IBA |
21873635 |
GO:0045717 |
Biological process |
Negative regulation of fatty acid biosynthetic process |
IMP |
16326698 |
GO:0045739 |
Biological process |
Positive regulation of DNA repair |
IMP |
17525340, 17643121, 19261748 |
GO:0045766 |
Biological process |
Positive regulation of angiogenesis |
IMP |
23415688 |
GO:0045892 |
Biological process |
Negative regulation of transcription, DNA-templated |
IDA |
16288014 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IDA |
20160719 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
NAS |
15572661 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
TAS |
10918303 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
16331276 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IMP |
20820192 |
GO:0046600 |
Biological process |
Negative regulation of centriole replication |
NAS |
12214252 |
GO:0051571 |
Biological process |
Positive regulation of histone H3-K4 methylation |
IDA |
20820192 |
GO:0051573 |
Biological process |
Negative regulation of histone H3-K9 methylation |
IDA |
20820192 |
GO:0051865 |
Biological process |
Protein autoubiquitination |
IDA |
12890688, 20351172 |
GO:0070512 |
Biological process |
Positive regulation of histone H4-K20 methylation |
IDA |
20820192 |
GO:0071158 |
Biological process |
Positive regulation of cell cycle arrest |
IBA |
21873635 |
GO:0071158 |
Biological process |
Positive regulation of cell cycle arrest |
IDA |
21102443 |
GO:0071356 |
Biological process |
Cellular response to tumor necrosis factor |
IMP |
23415688 |
GO:0071681 |
Biological process |
Cellular response to indole-3-methanol |
IDA |
10868478 |
GO:0072425 |
Biological process |
Signal transduction involved in G2 DNA damage checkpoint |
IMP |
17525340, 17643121, 19261748 |
GO:0085020 |
Biological process |
Protein K6-linked ubiquitination |
IDA |
12890688, 20351172 |
GO:1902042 |
Biological process |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
IMP |
23415688 |
GO:2000378 |
Biological process |
Negative regulation of reactive oxygen species metabolic process |
IMP |
23415688 |
GO:2000617 |
Biological process |
Positive regulation of histone H3-K9 acetylation |
IDA |
20820192 |
GO:2000620 |
Biological process |
Positive regulation of histone H4-K16 acetylation |
IDA |
20820192 |
GO:0000151 |
Cellular component |
Ubiquitin ligase complex |
NAS |
14976165 |
GO:0000800 |
Cellular component |
Lateral element |
IDA |
9774970 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
17525340, 17643121, 20160719, 23855721 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
20160719 |
GO:0005886 |
Cellular component |
Plasma membrane |
IBA |
21873635 |
GO:0005886 |
Cellular component |
Plasma membrane |
IDA |
21282464 |
GO:0008274 |
Cellular component |
Gamma-tubulin ring complex |
NAS |
12214252 |
GO:0031436 |
Cellular component |
BRCA1-BARD1 complex |
IBA |
21873635 |
GO:0031436 |
Cellular component |
BRCA1-BARD1 complex |
IDA |
12890688, 15265711, 19117993, 20351172 |
GO:0032991 |
Cellular component |
Protein-containing complex |
IDA |
9774970 |
GO:0070531 |
Cellular component |
BRCA1-A complex |
IBA |
21873635 |
GO:0070531 |
Cellular component |
BRCA1-A complex |
IDA |
17525340, 17525341, 17525342, 19261748, 19261749 |
GO:1990904 |
Cellular component |
Ribonucleoprotein complex |
IDA |
18809582 |
GO:0003677 |
Molecular function |
DNA binding |
TAS |
9662397 |
GO:0003713 |
Molecular function |
Transcription coactivator activity |
IMP |
9662397 |
GO:0003713 |
Molecular function |
Transcription coactivator activity |
NAS |
15572661 |
GO:0003723 |
Molecular function |
RNA binding |
IDA |
12419249 |
GO:0004842 |
Molecular function |
Ubiquitin-protein transferase activity |
IBA |
21873635 |
GO:0004842 |
Molecular function |
Ubiquitin-protein transferase activity |
IDA |
12890688, 17349954, 19117993, 20351172 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
8944023, 9497340, 9528852, 9662397, 9774970, 9811458, 10477523, 10855792, 11090615, 11301010, 11739404, 11751867, 11836499, 11877377, 12242698, 12419185, 12607005, 14550570, 14576433, 14654789, 15107825, 15265711, 15674350, 15965487, 16326698, 16452482, 17334399, 17511879, 17525332 |
GO:0015631 |
Molecular function |
Tubulin binding |
NAS |
12214252 |
GO:0019899 |
Molecular function |
Enzyme binding |
IPI |
15965487 |
GO:0031625 |
Molecular function |
Ubiquitin protein ligase binding |
IPI |
17873885 |
GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
8944023, 29656893 |
GO:0044212 |
Molecular function |
Transcription regulatory region DNA binding |
IDA |
20820192 |
GO:0050681 |
Molecular function |
Androgen receptor binding |
NAS |
15572661 |
GO:0070063 |
Molecular function |
RNA polymerase binding |
IDA |
9662397 |
|
Protein Information |
|
Protein Name |
Breast cancer type 1 susceptibility protein, BRCA1/BRCA2-containing complex, subunit 1, Fanconi anemia, complementation group S, RING finger protein 53, breast and ovarian cancer susceptibility protein 1, breast cancer 1, early onset, early onset breast cancer 1, protein phosphatase 1, regulatory subunit 53 |
|
Function |
|
|
|
|
|
UniProt |
|
|
PDB |
4JLU, 4U4A, 4Y18, 4Y2G, 3COJ, 6G2I, 4IGK, 1JM7, 4IFI, 1JNX, 1N5O, 1OQA, 1T15, 1T29, 1T2U, 1T2V, 1Y98, 2ING, 3K0H, 3K0K, 3K15, 3K16, 3PXA, 3PXB, 3PXC, 3PXD, 3PXE, 4OFB |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000352071 |
|
Q86VB7 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Blood Disorders |
Fanconi Anemia |
|
Anemia |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Keratoderma |
|
Digestive System Diseases |
Disease of mouth |
|
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Hereditary Breast and Ovarian Cancer Syndrome |
24578176, 27741520, 25748678, 10951344, 12491487, 18694767, 11157798, 9150151, 12402341, 26843898, 25476495, 16905680, 11748305, 12505256, 11106241, 10634513, 22703879, 15353005, 26622941, 18819001, 24884479, 11437933, 17453335, 23884293, 21990165, 15883839, 21751003, 12491499, 1965 |
Breast Cancer |
11114888, 21473589, 7545954, 8723683, 9760198, 7939630, 15133502, 12442275, 7894493, 10323242, 8554067, 12938098, 12427738, 9482581, 28364669, 7894491, 9609997, 9528852, 11301010, 14722926, 18285836, 23867111, 17924331, 8776600, 20135344, 26379698, 18066063, 26629949, 20941507, 15750, 28825726, 21781528, 10788334, 15750629, 15894690, 22614657, 25741868, 22333603, 20301425, 10980541, 21918854, 11733976, 11956590, 22486713, 855, 27257965, 24884479, 23469205, 15365993 |
Heriditary Neoplastic Syndrome |
27081505, 9667259, 18783588, 11949836, 17826769, 19863560, 23885733, 22923021, 25823446, 15026808, 7611277, 15172985, 25556971, 18493658, 24569164, 24285858, 10952777, 22144684, 25248401, 18679828, 19656164, 9699640, 15235020, 15024741, 12732733, 12505256, 26541979, 15642173, 198264 |
Adenoid Cystic Carcinoma |
|
Ovarian Cancer |
|
Breast Cancer,Male |
11301010, 12442275, 7894491, 14722926, 10323242, 7939630, 28364669, 18285836, 21473589, 8776600, 9609997, 9760198, 8554067, 8723683, 12427738, 7894493, 9482581, 12938098, 11114888, 15133502, 7545954, 23867111 |
Pancreatic Neoplasm |
|
Rhabdomyoma |
|
Prostate cancer |
17585057, 22516946, 27317574, 27742670, 28031937, 26236408, 27989354, 26926928, 27306910, 27899188, 26360800, 27433846, 27188668 |
Carcinoma |
|
Hematologic Neoplasms |
|
Dysgerminoma |
|
Anaplastic Carcinoma |
|
Psychiatric/Brain disorders |
Mental Depression |
|
Schizophrenia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
TP53, BRCA2 |
Hyperandrogenism, acne, hirsutism, obesity, oligoanovulation and infertility, insulin resistance |
rs71361504 -/GTT, rs3092986?T/C |
Rotterdam consensus criteria |
Direct
|
One hundred and ten women of reproductive age with PCOS and one hundred and thirty healthy women |
TheTP53andBRCA1may constitute an inheritable risk factor for PCOS in South Indian women |
|
|
|
|